A client with liver cirrhosis is prescribed spironolactone to manage fluid retention. Which laboratory test should the nurse monitor closely while the client is on this medication?
A. Serum potassium levels
B. Blood glucose levels
C. White blood cell count
D. Serum calcium levels
The Correct Answer and Explanation is:
Correct Answer: A. Serum potassium levels
Explanation:
Spironolactone is a potassium-sparing diuretic commonly prescribed to manage fluid retention, particularly in conditions like liver cirrhosis where ascites (fluid buildup in the abdomen) is a common complication. This medication works by antagonizing aldosterone, a hormone that promotes sodium and water retention in exchange for potassium excretion in the kidneys. By blocking aldosterone’s effect, spironolactone allows sodium and water to be excreted, helping reduce fluid overload, while conserving potassium.
Given that spironolactone is potassium-sparing, serum potassium levels must be monitored closely. One of the significant risks of using this medication is hyperkalemia, or elevated potassium levels. Normal serum potassium levels range from 3.5 to 5.0 mEq/L. If potassium levels rise above this range, it can lead to severe complications such as cardiac arrhythmias, muscle weakness, and in extreme cases, cardiac arrest.
Patients with liver cirrhosis are already at an increased risk of electrolyte imbalances due to the liver’s impaired ability to metabolize and regulate substances within the body. Therefore, the combined use of spironolactone can increase the risk of dangerous elevations in potassium. Nurses should ensure that serum potassium is regularly monitored, especially during the initial stages of spironolactone therapy or when dosage adjustments are made. If hyperkalemia develops, the medication may need to be adjusted or discontinued, and dietary potassium intake may need to be restricted.
Incorrect Options:
- B. Blood glucose levels: Spironolactone does not have a significant effect on blood glucose levels, so monitoring glucose is not necessary in this context.
- C. White blood cell count: Spironolactone does not typically affect white blood cell count, making this an irrelevant choice for monitoring.
- D. Serum calcium levels: Spironolactone does not directly influence calcium levels, and thus, monitoring calcium is unnecessary.
In summary, serum potassium monitoring is critical for ensuring safe spironolactone use in managing fluid retention in clients with liver cirrhosis.